Medipal Holdings Vs. NovoCure Industry Stock Comparison

Buy

54

MEPDF
Medipal Holdings

Last Price:

13.24

Seasonality Move:

9.47%

Buy

75

NVCR
NovoCure

Last Price:

33.40

Seasonality Move:

-5.24%

Buy

54

Medipal Holdings (MEPDF) is a Buy

Is Medipal Holdings a Buy, Sell or Hold?

The current Medipal Holdings [MEPDF] share price is $13.24. The Score for MEPDF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
MEPDF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

75

NovoCure (NVCR) is a Buy

Is NovoCure a Buy, Sell or Hold?

The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MEPDF Stock Price Chart

What is Medipal Holdings's stock price today?

The Medipal Holdings share price today is $13.24
The current trend is relatively stagnant and MEPDF is experiencing slight buying pressure.

NVCR Stock Price Chart

What is NovoCure's stock price today?

The NovoCure share price today is $33.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

MEPDF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0	Sell
Relative Strength Index (14 RSI):	0.35	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(13.24 - 13.24)	Sell
Bollinger Bands (100):	(13.24 - 13.24)	Sell

NVCR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	3.78	Buy
Relative Strength Index (14 RSI):	75.34	Buy
Chaikin Money Flow:	1118573	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(16.36 - 28.56)	Buy
Bollinger Bands (100):	(14.7 - 22.78)	Buy

MEPDF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	13.24	Sell
20-day SMA:	13.24	Sell
50-day SMA:	13.24	Sell
200-day SMA:	14.12	Sell
8-day EMA:	13.24	Sell
20-day EMA:	13.24	Sell
50-day EMA:	13.25	Sell
200-day EMA:	3.91	Buy

NVCR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	29.6	Buy
20-day SMA:	23.68	Buy
50-day SMA:	19.33	Buy
200-day SMA:	17.9	Buy
8-day EMA:	29.53	Buy
20-day EMA:	25.45	Buy
50-day EMA:	21.38	Buy
200-day EMA:	19.88	Buy

Medipal Holdings Earnings Growth & MEPDF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.

Medipal Holdings Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

	Dec 2	Dec 3	Dec 4	Dec 5	Dec 6	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13
	Dec
	02	03	04	05	06	09	10	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):